Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2023 > Vol 4, №7 (2023) > Clinical features of the course of chronic heart failure with a new coronavirus infection

Clinical features of the course of chronic heart failure with a new coronavirus infection

Victoria V. Streltsova , Natalya V. Bagisheva , Anna V. Mordyk , Marina V. Moiseeva , Ivan G. Steinborm

For citation:


  • Abstract
  • About the Author
  • References

Abstract

According to statistics, the number of patients with chronic heart failure (CHF) is growing in Russia. The cause of CHF can be various comorbid conditions that will aggravate the course of CHF. 
Objective. To determine the clinical features of the course of CHF in the context of COVID-19. 
Materials and methods. The retrospective study included 210 patients with a confirmed diagnosis of CHF and COVID-19 hospitalized in the pulmonology department. To assess the course of CHF, we used data on the severity of CHF symptoms (severity of shortness of breath on the mMRC scale, chest pain, presence of edema, level of physical activity) and objective examination data (blood pressure level, pulse dynamics). 
Results and conclusions. The risk group for severe COVID-19 included patients over 60 years of age with concomitant diseases. The clinical picture is noteworthy: severe shortness of breath, significant limitation of physical activity, and swelling in some patients. Patients with CHF during the treatment of COVID-19 require mandatory correction of both the underlying and concomitant diseases to prevent decompensation of CHF and death from all causes.
Key words: chronic heart failure, COVID-19, clinic.

About the Author

Victoria V. Streltsova 1 , Natalya V. Bagisheva 1 , Anna V. Mordyk 1 , Marina V. Moiseeva 1 , Ivan G. Steinborm 1

1 Omsk State Medical University, Omsk, Russia

References

1. Поляков Д.С., Фомин И.В., Беленков Ю.Н. и др. Хроническая сердечная недостаточность в Российской Федерации: что изменилось за 20 лет наблюдения? Результаты исследования ЭПОХА – ХСН. Кардиология. 2021; 61 (4): 4–14. DOI: 10.18087/cardio.2021.4.n1628
Polyakov DS, Fomin IV, Belenkov YuN et al. Chronic heart failure in the Russian Federation: what has changed in 20 years of observation? The results of the EPOCH – CHF study. Cardiology. 2021; 61 (4): 4–14. DOI: 10.18087/cardio.2021.4.n1628 (in Russian).
2. Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016; (8): 7–13. DOI: 10.15829/1560-4071-2016-8-7-13
Fomin IV. Chronic heart failure in the Russian Federation: what we know today and what we should do. Russ J Cardiol. 2016; (8): 7–13. DOI: 10.15829/1560-4071-2016-8-7-13 (in Russian).
3. Гриневич В.Б., Губонина И.В., Дощицин В.Л. и др. Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный Консенсус 2020. Кардиоваскулярная терапия и профилактика. 2020; 19 (4): 2630. DOI: 10.15829/1728-8800-2020-2630
Grinevich VB, Gubonina IV, Dosh'icin VL et al. Features of management of comorbid patients during the pandemic of a new coronavirus infection (COVID-19). National Consensus 2020. Cardiovascular therapy and prevention. 2020; 19 (4): 2630. DOI: 10.15829/1728-8800-2020-2630 (in Russian).
4. World Health Organization. Coronavirus disease 2019 (COVID-19) situation. URL: https://www.who.int/docs/default–source/coronaviruse/situation–reports/20200308–sitrep–48–COVID-19 .pdf
5. Багишева Н.В., Моисеева М.В., Стрельцова В.В. и др. Возможности лабораторной диагностики повреждения миокарда при COVID-19: в фокусе хроническая сердечная недостаточность. Клинический разбор в общей медицине. 2022; (6): 14–8. DOI: 10.47407/kr2022.3. 6.00170
Bagisheva NV, Moiseeva MV, Strel'tsova VV et al. Opportunities for laboratory diagnosis of myocardial damage in COVID-19: focus on chronic heart failure. Clinical review for general practice. 2022; 3 (6): 14–8. DOI: 10.47407/kr2022.3.6.00170 (in Russian).
6. Моисеева М.В., Багишева Н.В., Мордык А.В. и др. Декомпенсация хронической сердечной недостаточности после COVID-19: клиническое наблюдение. Клинический разбор в общей медицине. 2023; 2 (4); 14–8. DOI: 10.47407/kr2023.4.2.00198
Moiseeva MV, Bagisheva NV, Mordyk AV et al. Decompensation of chronic heart failure after COVID-19: a clinical observation. Clinical review for general practice. 2023; 2 (4); 14–8. DOI: 10.47407/kr2023. 4.2.00198 (in Russian).
7. Zhou F, Yu T, Du R et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395 (10229): 1054–1062. DOI 10.1016/ S0140–6736(20)30566–3
8. Трухан Д.И., Филимонов С.Н., Темникова Е.А. Болезни сердечно-сосудистой системы: клиника, диагностика и лечение. Гериатрические аспекты в кардиологии. СПб.: СпецЛит, 2022. URL: https: // elibrary.ru/item.asp?id=48110916
Trukhan DI, Filimonov SN, Temnikova EA. Diseases of the cardiovascular system: clinic, diagnosis and treatment. Geriatric aspects in cardiology. St. Petersburg: SpetsLit, 2022. URL: https: //elibrary.ru/ item.asp?id=48110916 (in Russian).
9. Tan ZC, Fu LH, Wang DD et al. Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations. Zhonghua Xin Xue Guan Bing Za Zhi. 2020; 48 (0): E005. DOI: 10.3760/cma.j.issn.cn112148-20200213-00077
10. Багишева Н.В., Мордык А.В., Трухан Д.И. и др. Коррекция терапии сопутствующей хронической сердечной недостаточности и хронической обструктивной болезни легких у пациента с впервые выявленным туберкулезом легких: клинический случай. Consilium Medicum. 2022; 24 (3): 157–9. DOI: 10.26442/20751753.2022.3.201525
Bagisheva NV, Mordyk AV, Trukhan DI et al. Correction of therapy of concomitant chronic heart failure and chronic obstructive pulmonary disease in a patient with newly diagnosed pulmonary tuberculosis: a clinical case. Consilium Medicum. 2022; 24 (3): 157–9. DOI: 10.26442/ 20751753.2022.3.201525 (in Russian).
11. Мордык А.В., Багишева Н.В., Гусева Т.С. и др. Универсальные подходы к лечению острой респираторной инфекции и гриппа. Лечащий врач. 2023; 26 (7–8): 63–8. DOI: 10.51793/OS.2023.26.8.009
Mordyk AV, Bagisheva NV, Guseva TS et al. Universal approaches to the treatment of acute respiratory infection and influenza. Lechashchiy vrach. 2023; 26 (7–8): 63–8. DOI: 10.51793/OS.2023.26.8.009 (in Russian).
12. Цветков В.В., Токин И.И., Лиознов Д.А. и др. Прогнозирование длительности стационарного лечения пациентов с COVID-19. Медицинский совет. 2020; (17): 82–90. DOI: 10.21518/2079-701X-2020-17-82-90
Tsvetkov VV, Tokin II, Lioznov DA et al. Predicting the duration of inpatient treatment of patients with COVID-19. Meditsinskiy sovet. 2020; (17): 82–90. DOI:10.21518/2079-701X-2020-17-82-90 (in Russian).
13. Henry C, Zaizafoun M, Stock E et al. Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia. Proc (Bayl Univ Med Cent). 2018; 31 (4): 419–23. DOI: 10.1080/08998280.2018.1499293
14. Voulgari C, Tentolouris N, Dilaveris P et al. Increased Heart Failure Risk in NormalWeight People With Metabolic Syndrome Compared With Metabolically Healthy Obese Individuals. J Am Coll Cardiol 2011; 58 (13): 1343–50. DOI: 10.1016/j.jacc.2011.04.047
15. Virani SS, Alonso A, Aparicio HJ et al.  Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021; 143 (8): e254–743.
16. Ata F, Montoro-Lopez MN, Awouda S et al. COVID-19 and Heart Failure: The Big Challenge. Heart Views. 2020; 21 (3): 187–92. DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_122_20

For citation:Streltsova V.V., Bagisheva N.V., Mordyk A.V. et al. Clinical features of the course of chronic heart failure with a new coronavirus infection. Clinical review for general practice. 2023; 4 (7): 26–29 (In Russ.). DOI: 10.47407/kr2023.4.7.00282


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru